Overall GHSI gets a fundamental rating of 5 out of 10. We evaluated GHSI against 36 industry peers in the Personal Care Products industry. No worries on liquidiy or solvency for GHSI as it has an excellent financial health rating, but there are worries on the profitability. GHSI is quite expensive at the moment. It does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 99.1% | ||
| GM | 44.84% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.72 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 16.67 | ||
| Quick Ratio | 16.59 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.56 | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 153.85% |
3.25
-0.01 (-0.31%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 153.85% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.56 | ||
| Fwd PE | N/A | ||
| P/S | 0.68 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.32 | ||
| P/tB | 0.32 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 99.1% | ||
| GM | 44.84% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 16.67 | ||
| Quick Ratio | 16.59 | ||
| Altman-Z | -5.72 |
ChartMill assigns a fundamental rating of 5 / 10 to GHSI.
ChartMill assigns a valuation rating of 2 / 10 to GUARDION HEALTH SCIENCES INC (GHSI). This can be considered as Overvalued.
GUARDION HEALTH SCIENCES INC (GHSI) has a profitability rating of 3 / 10.
The Earnings per Share (EPS) of GUARDION HEALTH SCIENCES INC (GHSI) is expected to decline by -669.3% in the next year.